Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Germany
  • +34 96 390 53 10 Anfrage Informationen
  • +34 96 390 53 10 Anfrage Informationen
GermanyGermany
  • Germany
  • Fertilität
  • REPRODUKTIONSMEDIZIN
    • Gesundheitsexperte
      • ALICE
      • EMMA
      • ERA-Test
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • PGT-M
      • POC
      • SAT
    • Patient
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • PGT-M
      • SAT
      • POC
  • ÜBER UNS
    • Igenomix Entwicklung
    • Über Igenomix
  • WEBINARS
Genomics Precision Diagnostic > Ear, Nose, Throat Precision Panel > Waardenburg Syndrome Precision Panel

Waardenburg Syndrome Precision Panel

Waardenburg Syndrome (WS) is a genetic disorder characterized by the association of pigmentation abnormalities, including depigmented patches of the skin and hair, blue eyes (heterochromia irides), and sensorineural hearing loss.
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Waardenburg Syndrome (WS) is a genetic disorder characterized by the association of pigmentation abnormalities, including depigmented patches of the skin and hair, blue eyes (heterochromia irides), and sensorineural hearing loss. It also presents with other clinical features involving musculoskeletal abnormalities, gastrointestinal malformations and neurological defects. WS is considered a defect in the melanocyte and neural crest development, where a complex interconnecting regulatory network of genes work in synergism for an appropriate development of melanocytes. It is typically inherited in an autosomal dominant pattern.  

  • The Igenomix Waardenburg Syndrome Precision Panel can be used to make an accurate and directed diagnosis as well as a differential diagnosis of hearing loss ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

Indication

  • The Igenomix Waardenburg Syndrome Precision Panel is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations: 
    • Cleft lip 
    • Constipation 
    • Deafness 
    • Extremely pale blue eyes or nonmatching eye colors
    • Pale color skin, hair and eyes 
    • Decreased intellectual function 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team in the form of hearing aids and cochlear implants, social services and speech therapy.
  • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
  • Improvement of delineation of genotype-phenotype correlation. 
  • Unravel important developmental pathways in the neural crest and derivatives that could potentially lead to Waardenburg Syndrome.

Genes & Diseases

See all genes and diseases

GENE 

OMIM DISEASES 

INHERITANCE* 

% GENE COVERAGE (20X) 

HGMD** 

EDN3 

Congenital
Failure Of
Autonomic
Control,
Waardenburg
Syndrome, 
Ondine 
Syndrome,
Waardenburg-
Shah
Syndrome
 

AD,AR 

100 

20 of 22 

EDNRB 

Abcd Syndrome,
Waardenburg-
Shah
Syndrome,
Waardenburg
Syndrome
 

AD,AR 

99.55 

70 of 72 

KIT 

Gastrointestinal
Stromal
Tumor, Acute
Myeloid
 
Leukemia, Mast
Cell
Disease, Piebald
Trait
 

AD 

100 

112 of 112 

KITLG 

Autosomal
Dominant
Deafness,
Familial
Progressive
Hyperpigmentation,
Waardenburg
Syndrome
 

AD 

99.93 

10 of 10 

MITF 

Coloboma,
Osteopetrosis
, 
Microphthalmia, 
Macrocephaly,
 
Albinism,
And 
Deafness, 
Tietz Syndrome, 
Waardenburg 
Syndrome, 
Waardenburg-Shah 
Syndrome 

AD,AR 

100 

72 of 72 

PAX3 

Craniofacial-Deafness-
Hand Syndrome,
Alveolar
Rhabdo-
myosarcoma,
Waardenburg
Syndrome,
Craniofacial-
Deafness-H
and
Syndrome
 

AD,AR 

99.98 

157 of 157 

SMOC1 

Microphthalmia 
With Limb 
Anomalies 

AR 

100 

19 of 19 

SNAI2 

Piebald Trait, 
Waardenburg 
Syndrome 

AD,AR 

99.79 

1 of 2 

SOX10 

Peripheral
Demyelinating
Neuropathy,
Central 
Dysmyelination,
Waardenburg
Syndrome,
Waardenburg-
Shah Syndrome
 

AD 

99.74 

139 of 147 

 * Inheritance: AD: Autosomal Dominant; AR: Autosomal Recessive; X: X linked; XLR: X linked Recessive; Mi: Mitochondrial; Mu: Multifactorial 

** HGMD: Number of clinically relevant mutations according to HGMD 

Methodology

References

See scientific referrals

Pingault, V., Ente, D., Dastot-Le Moal, F., Goossens, M., Marlin, S., & Bondurand, N. (2010). Review and update of mutations causing Waardenburg syndrome. Human mutation, 31(4), 391–406. https://doi.org/10.1002/humu.21211 

Saleem M. D. (2019). Biology of human melanocyte development, Piebaldism, and Waardenburg syndrome. Pediatric dermatology, 36(1), 72–84. https://doi.org/10.1111/pde.13713 

Ren, S., Chen, X., Kong, X., Chen, Y., Wu, Q., Jiao, Z., & Shi, H. (2020). Identification of six novel variants in Waardenburg syndrome type II by next‐generation sequencing. Molecular Genetics & Genomic Medicine, 8(3). doi: 10.1002/mgg3.1128 

Read, A. P., & Newton, V. E. (1997). Waardenburg syndrome. Journal of medical genetics, 34(8), 656–665. https://doi.org/10.1136/jmg.34.8.656 

Tagra, S., Talwar, A. K., Walia, R. L., & Sidhu, P. (2006). Waardenburg syndrome. Indian journal of dermatology, venereology and leprology, 72(4), 326. https://doi.org/10.4103/0378-6323.26718 

Ringer J. (2019). Identification of Waardenburg Syndrome and the Management of Hearing Loss and Associated Sequelae: A Review for the Pediatric Nurse Practitioner. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners, 33(6), 694–701. https://doi.org/10.1016/j.pedhc.2019.06.001 

Minami, S. B., Nara, K., Mutai, H., Morimoto, N., Sakamoto, H., Takiguchi, T., Kaga, K., & Matsunaga, T. (2019). A clinical and genetic study of 16 Japanese families with Waardenburg syndrome. Gene, 704, 86–90. https://doi.org/10.1016/j.gene.2019.04.023 

BROCHURE

Download

Request Information











  • reCAPTCHA demo: Simple page












  • Fertilität

    Klicken Sie auf diesen Link, um das Akkreditierungszertifikat, den zugehörigen technischen Anhang und die Liste der akkreditierten Tests anzuzeigen..

    Unsere Services

    Gesundheitsexperte
    Patient
    Einsenden proben
    User manual

    Über uns

    Über Igenomix
    Kontakt
    Qualität
    Arbeite mit uns

      + 96 390 53 10
    Schreiben Sie uns
    • Argentina
    • Brazil
    • Canada
    • Chile
    • China
    • Colombia
    • Europe
    • France
    • Germany
    • India
    • Italy
    • Japan
    • Korea
    • Mexico
    • Perú
    • Russia
    • Spain
    • Taiwan
    • The Middle East
    • Turkey
    • United Kingdom
    • United States
    • Vietnam
    Germany

    [2021] © Igenomix Datenschutz Qualitätsrichtlinie
    Rechtliche Hinweise Cookie-Richtlinie

    Anfrage Informationen


    • reCAPTCHA demo: Simple page

    • Fertilität
    • REPRODUKTIONSMEDIZIN
      • Gesundheitsexperte
        • ALICE
        • EMMA
        • ERA-Test
        • EndomeTRIO
        • EMBRACE
        • CGT
        • NACE
        • PGT-M
        • POC
        • SAT
      • Patient
        • ALICE
        • EMMA
        • ERA
        • EndomeTRIO
        • EMBRACE
        • CGT
        • NACE
        • PGT-M
        • SAT
        • POC
    • ÜBER UNS
      • Igenomix Entwicklung
      • Über Igenomix
    • WEBINARS
    • Germany
    • +34 96 390 53 10 Anfrage Informationen